Stocks in Action: Concho Resources Inc, Charles River Laboratories, Fusion-IO, Avanir Pharmaceuticals

Dallas, TX -- (SBWIRE) -- 03/14/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Concho Resources Inc. (NYSE:CXO) shares gained 2.85% to $94.09. CXO’s stock was upgraded by research analysts at Iberia Capital to a “sector perform” rating in a report released on Feb. 22.

Additionally, the company announced its earnings results on Feb. 20. The company reported $0.72 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.01 by $0.29. The company had revenue of $477.53 million for the quarter, compared to the consensus estimate of $526.42 million.

Get Latest News, Updates on CXO Here

Charles River Laboratories(NYSE:CRL) shares gained 2.83% to $45.79 in the last trading session. CRL’s stock had its target price lifted by ISI Group from $40.50 to $43.00 in a report issued on Feb. 14. They currently have a neutral rating on the stock. Additionally, analysts at Robert W. Baird raised their price target on shares of Charles River Laboratories from $43.00 to $45.00 in a research note to investors on Thursday, January 17th. They now have an outperform rating on the stock.

Is CRL a Strong Buying Opportunity After The Recent Slump? Find out Here

Fusion-IO, Inc.(NYSE:FIO) shares increased 2.82% and closed at $17.52. The company, on Jan. 30, announced that for the third quarter of 2013, it expects revenue to be approximately $80 million. For fiscal 2013, it expects revenue to be approximately $420 to $440 million. Analysts are expecting the Company to report revenues of $137 million for the third quarter of 2013 and revenues of $530 for fiscal 2013.

Is FIO Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) shares gained 2.71% and closed at $3.03. The company on Mar. 11 announced the appointment of Ms. Corinne Nevinny to the company's board of directors. Ms. Nevinny, a seasoned life sciences executive joins Avanir's board with broad healthcare industry experience across multiple disciplines. Ms. Nevinny is General Partner of LMNVC LLC, a privately held early stage venture firm, which she founded in October 2010.

Is AVNR Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.